Recombinant human erythropoietin treatment: Investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome: Overall results

Archives of Internal Medicine

Volumn 153, Issue 23, 1993, Pages 2669-2675

  Phair, J P ^a   Abels, R I ^a   McNeill, M V ^a   Sullivan, D J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT ERYTHROPOIETIN; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGED; ANEMIA; ARTICLE; BLOOD TOXICITY; BLOOD TRANSFUSION; CONTROLLED STUDY; DRUG EFFICACY; ERYTHEMA; FEMALE; HEMATOCRIT; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RASH; SUBCUTANEOUS DRUG ADMINISTRATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGED; ANEMIA; BLOOD TRANSFUSION; COMBINED MODALITY THERAPY; DRUGS, INVESTIGATIONAL; ERYTHROPOIETIN; FEMALE; HEMATOCRIT; HUMAN; MALE; MIDDLE AGE; RECOMBINANT PROTEINS; TREATMENT OUTCOME; ZIDOVUDINE;

EID: 0027429347     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.153.23.2669     Document Type: Article

References (0)